Testbank for Karch’s Focus on Nursing Pharmacology, 9th Edition
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Karch’s Focus on Nursing Pharmacology, 9th Edition
Corrected & Chapter-Aligned Independent Practice TestBank
TestBank features: 1,135 final single-best-answer questions; 60 chapter headings; 11 parts; standardized rationales; rendered diagrams/graphs; balanced A–D
answers; and a complete master answer key.
Important: This is an independent study resource and is not an official publisher test bank. The chapter organization follows the 9th-edition structure. Guideline-
sensitive medication decisions should always be checked against current official product labeling and institutional policy.
Premium Feature Included
Traditional single-best-answer MCQs Four options A–D with one correct answer
Detailed rationales Correct-answer reasoning plus why alternatives are less
appropriate
Clinical pearls High-yield medication-safety and pharmacology connections
Exam strategies Decision cues for nursing pharmacology questions
Calculations/data interpretation Dose, infusion, trends, tables and graph interpretation
Word-visible visuals Rendered flow diagrams, real charts, stable tables and
sketches
Navigation Part/chapter headings, clickable contents and page numbers
Answer integrity One final answer per question; no drafting notes or forced-
answer commentary
Page 2 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Table of Contents
Part / Chapter Title Questions Count Page
PART 1 Introduction to Nursing 150
Pharmacology
Chapter 1 Introduction to Drugs 1–4 4 —
Chapter 2 Drugs and the Body 5–53 49 —
Chapter 3 Toxic Effects of Drugs 54–87 34 —
Chapter 4 The Nursing Process in 88–107 20 —
Drug Therapy and Patient
Safety
Chapter 5 Dosage Calculations 108–138 31 —
Chapter 6 Challenges to Effective 139–150 12 —
Drug Therapy
PART 2 Chemotherapeutic Agents 150
Chapter 7 Introduction to Cell 151–162 12 —
Physiology
Chapter 8 Antiinfective Agents 163–178 16 —
Chapter 9 Antibiotics 179–207 29 —
Chapter 10 Antiviral Agents 208–227 20 —
Chapter 11 Antifungal Agents 228–244 17 —
Chapter 12 Antiprotozoal Agents 245–260 16 —
Chapter 13 Anthelmintic Agents 261–273 13 —
Chapter 14 Antineoplastic Agents 274–300 27 —
PART 3 Drugs Acting on the Immune 150
System
Chapter 15 Introduction to the Immune 301–339 39 —
Response and
Inflammation
Chapter 16 Antiinflammatory, 340–378 39 —
Antiarthritis, and Related
Agents
Chapter 17 Immune Modulators 379–420 42 —
Chapter 18 Vaccines and Sera 421–450 30 —
PART 4 Drugs Acting on the Central 150
and Peripheral Nervous
Systems
Chapter 19 Introduction to Nerves and 451–462 12 —
the Nervous System
Chapter 20 Anxiolytic and Hypnotic 463–480 18 —
Agents
Chapter 21 Antidepressant Agents 481–493 13 —
Chapter 22 Psychotherapeutic Agents 494–512 19 —
Chapter 23 Antiseizure Agents 513–531 19 —
Chapter 24 Antiparkinsonism Agents 532–550 19 —
Chapter 25 Muscle Relaxants 551–555 5 —
Chapter 26 Opioid Agonists, Opioid 556–575 20 —
Antagonists, and
Antimigraine Agents
Chapter 27 General and Local 576–585 10 —
Anesthetic Agents
Chapter 28 Neuromuscular Junction 586–600 15 —
Blocking Agents
PART 5 Drugs Acting on the 80
Autonomic Nervous System
Chapter 29 Introduction to the 601–610 10 —
Autonomic Nervous System
Chapter 30 Adrenergic Agonists 611–625 15 —
Chapter 31 Adrenergic Antagonists 626–640 15 —
Chapter 32 Cholinergic Agonists 641–655 15 —
Chapter 33 Anticholinergic Agents 656–680 25 —
PART 6 Drugs Acting on the Endocrine 75
System
Chapter 34 Introduction to the 681–690 10 —
Endocrine System
Page 3 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 35 Hypothalamic and Pituitary 691–705 15 —
Agents
Chapter 36 Adrenocortical Agents 706–720 15 —
Chapter 37 Thyroid and Parathyroid 721–735 15 —
Agents
Chapter 38 Agents to Control Blood 736–755 20 —
Glucose Levels
PART 7 Drugs Acting on the 75
Reproductive System
Chapter 39 Introduction to the 756–765 10 —
Reproductive System
Chapter 40 Drugs Affecting the Female 766–795 30 —
Reproductive System
Chapter 41 Drugs Affecting the Male 796–830 35 —
Reproductive System
PART 8 Drugs Acting on the 80
Cardiovascular System
Chapter 42 Introduction to the 831–840 10 —
Cardiovascular System
Chapter 43 Drugs Affecting Blood 841–850 10 —
Pressure
Chapter 44 Agents for Treating Heart 851–860 10 —
Failure
Chapter 45 Antiarrhythmic Agents 861–870 10 —
Chapter 46 Antianginal Agents 871–880 10 —
Chapter 47 Lipid-Lowering Agents 881–890 10 —
Chapter 48 Drugs Affecting Blood 891–900 10 —
Coagulation
Chapter 49 Drugs Used to Treat 901–910 10 —
Anemias
PART 9 Drugs Acting on the Renal 75
System
Chapter 50 Introduction to the Renal 911–925 15 —
System
Chapter 51 Diuretic Agents 926–960 35 —
Chapter 52 Drugs Affecting the Urinary 961–985 25 —
Tract and the Bladder
PART 10 Drugs Acting on the 75
Respiratory System
Chapter 53 Introduction to the 986–990 5 —
Respiratory System
Chapter 54 Drugs Acting on the Upper 991–1025 35 —
Respiratory Tract
Chapter 55 Drugs Acting on the Lower 1026–1060 35 —
Respiratory Tract
PART 11 Drugs Acting on the 75
Gastrointestinal System
Chapter 56 Introduction to the 1061–1075 15 —
Gastrointestinal System
Chapter 57 Drugs Affecting 1076–1095 20 —
Gastrointestinal Secretions
Chapter 58 Drugs Affecting 1096–1115 20 —
Gastrointestinal Motility
Chapter 59 Antiemetic Agents 1116–1125 10 —
Chapter 60 Vitamins, Minerals, and 1126–1135 10 —
Complementary/Alternative
Medications
Page 4 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
PART 1 — Introduction to Nursing Pharmacology
Page 5 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 1 — Introduction to Drugs
Question 1
A medication reference lists three names for the same drug: a chemical name, a generic name, and a trade name. Which statement by a nursing student indicates
correct understanding?
A. “The generic name identifies the drug independent of a manufacturer's brand.”
B. “The trade name always describes the medication's chemical structure.”
C. “The chemical name is normally used when administering medications clinically.”
D. “A generic medication must contain a different active ingredient from the brand product.”
Correct Answer: A
Rationale: The generic name is the accepted nonproprietary name of the medication and is not owned as a manufacturer's trademark. Brand or trade names are
assigned by manufacturers. Chemical names describe molecular composition and are typically too complex for routine clinical use.
Why the other options are less appropriate:
B: Trade names are commercial names rather than chemical descriptions.
C: Chemical names are rarely used in routine medication administration.
D: Generic and brand formulations contain the same active medication when equivalent products are compared.
💡 Clinical Pearl: Nurses should become especially comfortable with generic drug names because multiple brands may exist.
🎯 Exam Strategy: Generic = standard name; trade = manufacturer's marketed name.
Question 2
A faculty member asks students to identify the field concerned with selecting and using medications to prevent and treat disease. Which response is correct?
A. Pharmacotherapeutics
B. Pharmacokinetics
C. Toxicology
D. Pharmacognosy
Correct Answer: A
Rationale: Pharmacotherapeutics focuses on the clinical application of medications in preventing, diagnosing, and treating disease. It connects knowledge of drug
action with the therapeutic needs of an individual patient. Nurses use pharmacotherapeutic principles when evaluating whether medication therapy is achieving its
intended clinical outcome.
Why the other options are less appropriate:
B: Pharmacokinetics concerns movement of drugs through the body.
C: Toxicology focuses on harmful effects of chemicals and drugs.
D: Pharmacognosy traditionally concerns drugs derived from natural sources.
💡 Clinical Pearl: Therapeutics = treatment.
🎯 Exam Strategy: Words such as treat, prevent, and clinical use usually point toward pharmacotherapeutics.
Question 3
A medication order requires a trough serum concentration. When should the specimen generally be obtained?
A. Immediately before the next scheduled dose
B. At the expected peak effect
C. Immediately after administration
D. Halfway through the infusion regardless of medication
Correct Answer: A
Rationale: A trough concentration reflects the lowest serum level during a dosing interval and is generally collected immediately before the next dose. Correct timing is
essential because an incorrectly timed sample may lead to inappropriate dose adjustment.
Why the other options are less appropriate:
B: Peak testing measures a different point in the concentration curve.
C: Immediately after administration may reflect a high level.
D: Mid-infusion measurement is not the standard definition of trough.
💡 Clinical Pearl: Always document the exact dose time and specimen time when therapeutic drug monitoring is performed.
🎯 Exam Strategy: Trough = just before.
Question 4
Drug X alone decreases a physiologic response by 20%. Drug Y alone decreases it by 20%, but when administered together the response decreases by 70%. Which
relationship is illustrated?
A. Competitive antagonism
B. Simple tolerance
C. Therapeutic equivalence
D. Synergism
Correct Answer: D
Rationale: Synergism occurs when the combined effect of two drugs exceeds what would be expected from simple addition of their individual effects. This interaction
can be therapeutically useful or potentially dangerous.
Why the other options are less appropriate:
A: Antagonism reduces another drug's effect.
B: Tolerance reflects diminished response with repeated exposure.
C: Therapeutic equivalence does not describe enhanced combined action.
💡 Clinical Pearl: Additive = 1 + 1 ≈ 2; synergistic = 1 + 1 > 2.
🎯 Exam Strategy: Combined effect dramatically exceeds expected sum = synergy.
Page 6 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 2 — Drugs and the Body
Question 5
During an interdisciplinary conference, a student describes a medication as producing its clinical benefit by attaching to specific cellular receptors and altering cellular
activity. Which pharmacologic concept is the student describing?
A. Pharmacokinetics
B. Pharmacodynamics
C. Pharmacogenomics
D. Pharmacotherapeutics
Correct Answer: B
Rationale: Pharmacodynamics describes what a drug does to the body, including receptor binding, biochemical effects, and the relationship between drug
concentration and therapeutic or toxic responses. Receptor activation or inhibition is therefore primarily a pharmacodynamic process. Understanding this distinction
helps nurses anticipate intended actions as well as receptor-mediated adverse effects.
Why the other options are less appropriate:
A: Pharmacokinetics describes what the body does to the drug through absorption, distribution, metabolism, and excretion.
C: Pharmacogenomics examines genetic influences on medication response.
D: Pharmacotherapeutics concerns the clinical use of drugs to prevent or treat disease.
💡 Clinical Pearl: Think dynamics = drug effect and kinetics = drug movement.
🎯 Exam Strategy: When a question discusses receptors, agonists, antagonists, or cellular effects, think pharmacodynamics.
Question 6
A serum medication level remains unexpectedly elevated in an adult whose renal laboratory values have deteriorated during hospitalization. Which pharmacokinetic
process is most directly impaired?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: D
Rationale: The kidneys are major organs responsible for eliminating many medications and their metabolites. Reduced renal function can decrease drug clearance,
prolong the half-life, and cause accumulation. The nurse should recognize elevated medication concentrations as a potential sign that excretion has become
inadequate.
Why the other options are less appropriate:
A: Distribution refers to movement from circulation into tissues.
B: Absorption concerns movement from the administration site into circulation.
C: Metabolism is primarily associated with hepatic biotransformation.
💡 Clinical Pearl: Declining renal function often means lower doses or longer dosing intervals may be required.
🎯 Exam Strategy: Rising creatinine + accumulating drug level = think reduced renal clearance first.
Question 7
Two equal doses of a drug are prescribed. One is administered intravenously and the other orally. Which statement most accurately compares the routes?
A. Oral administration always produces a higher peak concentration.
B. IV medication must first pass through the gastrointestinal tract.
C. IV administration provides essentially immediate systemic availability.
D. Oral and IV medications have identical absorption characteristics.
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream and therefore bypasses the absorption step required by extravascular routes.
IV drugs generally produce rapid onset and complete systemic availability. Oral medications must dissolve, cross gastrointestinal membranes, and may undergo first-
pass hepatic metabolism.
Why the other options are less appropriate:
A: Oral drugs generally do not achieve faster or more reliable peaks than IV administration.
B: IV drugs bypass the gastrointestinal tract.
D: Their pharmacokinetic profiles differ substantially.
💡 Clinical Pearl: IV medication has no absorption barrier, which contributes to both rapid benefits and rapid toxicity.
🎯 Exam Strategy: When comparing administration routes, remember IV = fastest and most directly bioavailable.
Question 8
A medication reconciliation reveals that the hospital admission list omits a patient's long-term anticoagulant. What is the nurse's priority action?
A. Add the medication independently to the electronic MAR.
B. Clarify the discrepancy before continuing the medication plan.
C. Wait until discharge reconciliation to address the omission.
D. Tell the patient to take medication brought from home.
Correct Answer: B
Rationale: Medication reconciliation is designed to identify omissions, duplications, dosing discrepancies, and interactions during transitions in care. An omitted
anticoagulant may place the patient at significant risk, but restarting it also requires confirmation of current indications and contraindications. The discrepancy
therefore requires prompt clarification.
Why the other options are less appropriate:
A: Nurses generally cannot independently prescribe missing medications.
C: Waiting may expose the patient to preventable harm.
D: Unverified self-administration creates additional medication-safety risks.
💡 Clinical Pearl: Transitions of care are particularly vulnerable periods for medication errors.
🎯 Exam Strategy: Reconciliation question + discrepancy = stop and clarify.
Page 7 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Pharmacokinetic Journey
Question 9
A medication taken orally requires a considerably larger dose than the same drug administered intravenously because much of the oral dose is metabolized before
reaching systemic circulation. Which process explains this difference?
A. First-pass effect
B. Receptor down-regulation
C. Renal filtration
D. Drug tolerance
Correct Answer: A
Rationale: After gastrointestinal absorption, many oral medications enter the portal circulation and travel to the liver before reaching systemic circulation. Hepatic
metabolism may inactivate part of the drug during this first passage. Consequently, the amount reaching systemic circulation may be lower than with IV administration.
Why the other options are less appropriate:
B: Receptor down-regulation concerns cellular responsiveness.
C: Renal filtration occurs after systemic circulation and primarily affects elimination.
D: Tolerance develops from repeated exposure and decreased responsiveness.
💡 Clinical Pearl: The first-pass effect can substantially reduce oral bioavailability.
🎯 Exam Strategy: Oral drug + liver metabolism before systemic circulation = first-pass effect.
Question 10
A pharmacology seminar examines a medication whose plasma concentration decreases from 80 mg/L to 40 mg/L in 6 hours. Which conclusion is most accurate?
A. The medication has reached steady state.
B. The therapeutic index is 6 hours.
C. The medication's half-life is approximately 6 hours.
D. Complete elimination occurs after 6 hours.
Correct Answer: C
Rationale: The half-life of a medication is the amount of time required for its plasma concentration to decrease by approximately 50%. A reduction from 80 mg/L to 40
mg/L therefore represents one half-life. Half-life helps determine dosing intervals, accumulation, and the approximate time required for a drug to reach steady state or
be eliminated.
Why the other options are less appropriate:
A: Steady state occurs when drug administration and elimination become approximately balanced.
B: Therapeutic index compares effective and toxic concentrations or doses.
D: One half-life removes only about 50%, not the entire medication.
💡 Clinical Pearl: After roughly 4–5 half-lives, most drugs approach steady state during repeated dosing.
🎯 Exam Strategy: When the concentration falls by exactly half, immediately think half-life.
Question 11
During a receptor-response simulation, Drug X binds to a receptor and produces the same type of cellular response as the body's naturally occurring ligand. How
should Drug X be classified?
A. Agonist
B. Antagonist
C. Enzyme inhibitor
D. Chelating agent
Correct Answer: A
Rationale: An agonist binds to a receptor and activates it, producing a biologic response. Some agonists imitate endogenous chemicals, while others stimulate the
receptor through a different molecular structure. Understanding agonist activity helps predict both desired therapeutic effects and receptor-mediated adverse
reactions.
Why the other options are less appropriate:
B: An antagonist binds without activating the receptor and limits agonist activity.
C: Enzyme inhibition affects metabolism rather than necessarily activating receptors.
D: Chelating agents bind specific substances such as certain metals.
💡 Clinical Pearl: Agonist = activates. Antagonist = blocks.
🎯 Exam Strategy: Look for wording such as stimulates, activates, mimics, or produces a response.
Question 12
Review of a newly prescribed medication shows that it occupies a receptor without activating it and prevents another substance from producing its usual response.
Which mechanism is occurring?
A. Synergism
B. Potentiation
C. Enzyme induction
D. Receptor antagonism
Correct Answer: D
Rationale: A receptor antagonist occupies the receptor but does not activate it. Its presence prevents or reduces the ability of an agonist or naturally occurring ligand to
produce its expected effect. Antagonists are frequently used therapeutically to reverse or limit excessive physiologic stimulation.
Why the other options are less appropriate:
A: Synergism occurs when combined substances produce an enhanced overall effect.
B: Potentiation occurs when one drug increases the effect of another.
C: Enzyme induction increases activity of metabolizing enzymes.
💡 Clinical Pearl: Many emergency reversal medications work through competitive receptor antagonism.
🎯 Exam Strategy: “Occupies but does not activate” is a classic clue for an antagonist.
Page 8 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Question 13
A medication-reconciliation note shows that the individual who cannot swallow is prescribed a medication by the sublingual route. What pharmacokinetic advantage
may this route provide for certain drugs?
A. Complete prevention of drug distribution
B. Rapid absorption with avoidance of much of the first-pass hepatic effect
C. Guaranteed prolonged duration of action
D. Elimination of all adverse effects
Correct Answer: B
Rationale: Sublingual medications can be absorbed through the highly vascular mucosa beneath the tongue and enter systemic circulation rapidly. This route can avoid
substantial first-pass hepatic metabolism because the medication does not first travel through the gastrointestinal tract and portal circulation. The exact advantage
depends on the drug's properties.
Why the other options are less appropriate:
A: Distribution still occurs after systemic absorption.
C: Sublingual administration does not guarantee prolonged action.
D: Adverse effects can still occur.
💡 Clinical Pearl: Sublingual drugs should generally be allowed to dissolve rather than swallowed immediately.
🎯 Exam Strategy: Route question + bypassing liver initially = think sublingual or certain other nonenteral routes.
Question 14
Neurologic rounds focus on why some medications enter brain tissue readily while others do not. Which physiologic structure most directly limits entry of many
substances into the central nervous system?
A. Hepatic portal system
B. Glomerular membrane
C. Blood-brain barrier
D. Gastric mucosa
Correct Answer: C
Rationale: The blood-brain barrier contains tightly connected capillary endothelial cells that restrict passage of many substances from blood into brain tissue. Lipid
solubility, molecular characteristics, transporter activity, and disease states influence whether a drug can cross it. This barrier is an important component of drug
distribution.
Why the other options are less appropriate:
A: The portal system primarily carries gastrointestinal blood to the liver.
B: The glomerulus participates in renal filtration.
D: Gastric mucosa affects absorption of certain substances.
💡 Clinical Pearl: Lipid-soluble medications generally cross cellular membranes more readily than highly ionized compounds.
🎯 Exam Strategy: Questions involving drug penetration into the brain should immediately raise the blood-brain barrier.
Question 15
A medication added to a patient's regimen stimulates hepatic enzymes that metabolize another long-term drug. What may happen to the second drug?
A. Its concentration and therapeutic effect may decrease.
B. Its absorption will necessarily become complete.
C. Its renal filtration will stop.
D. Its receptor affinity will always increase.
Correct Answer: A
Rationale: Enzyme induction increases metabolic enzyme activity and may accelerate metabolism of medications that are substrates for those enzymes. Faster
metabolism can lower serum concentrations and reduce therapeutic effectiveness. The clinical significance depends on the drugs involved and the magnitude of
enzyme induction.
Why the other options are less appropriate:
B: Enzyme induction does not guarantee complete gastrointestinal absorption.
C: It does not stop glomerular filtration.
D: Metabolism and receptor affinity are separate properties.
💡 Clinical Pearl: Enzyme induction often lowers concentrations; enzyme inhibition often raises them.
🎯 Exam Strategy: Memorize the directional relationship rather than isolated definitions.
Question 16
A trend report shows progressively declining renal function in a patient receiving a medication primarily eliminated unchanged in urine. Which adjustment might
eventually be required?
A. Automatic conversion to an intramuscular route
B. Reduction of dose or extension of the dosing interval
C. Addition of another nephrotoxic medication
D. Doubling the dose to improve effectiveness
Correct Answer: B
Rationale: When renal clearance decreases, medications eliminated primarily through the kidneys may remain in the circulation longer. Dose reduction, longer dosing
intervals, or both may be necessary to prevent accumulation. Exact modifications require drug-specific guidance and assessment of renal function.
Why the other options are less appropriate:
A: Changing the route does not necessarily solve impaired elimination.
C: Additional nephrotoxicity could worsen renal dysfunction.
D: Increasing the dose may markedly increase toxicity.
💡 Clinical Pearl: Always connect kidney function to drug clearance, especially for renally eliminated medications.
🎯 Exam Strategy: Renal impairment questions commonly test whether you recognize accumulation risk.
Receptor Activity
Page 9 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Question 17
A medication must achieve an effective plasma concentration rapidly, but its normal maintenance dose would require several dosing intervals to reach that
concentration. Which strategy may be used?
A. Elimination dose
B. Loading dose
C. Placebo dose
D. Rescue interaction
Correct Answer: B
Rationale: A loading dose is a comparatively larger initial dose intended to establish a therapeutic concentration more rapidly. Maintenance doses are then used to
replace drug eliminated from the body and keep the concentration within the desired range. Loading doses require particular caution when the therapeutic index is
narrow.
Why the other options are less appropriate:
A: “Elimination dose” is not the relevant pharmacologic strategy.
C: A placebo does not establish therapeutic drug concentrations.
D: This is not a standard dosing concept.
💡 Clinical Pearl: Loading gets you there; maintenance keeps you there.
🎯 Exam Strategy: Rapid attainment of therapeutic concentration = loading dose.
Question 18
Clinical monitoring is especially intensive for a medication whose effective concentration lies close to its toxic concentration. Which property explains the concern?
A. High bioavailability
B. Extensive first-pass metabolism
C. Long absorption time
D. Narrow therapeutic index
Correct Answer: D
Rationale: A narrow therapeutic index means there is a relatively small margin between therapeutic and toxic drug exposure. Small changes in dosage, metabolism,
renal function, or interacting medications may therefore result in toxicity or treatment failure. Serum drug levels may be required for certain medications in this
category.
Why the other options are less appropriate:
A: High bioavailability alone does not establish a narrow safety margin.
B: First-pass metabolism concerns oral bioavailability.
C: Absorption time does not define the toxic-to-therapeutic relationship.
💡 Clinical Pearl: Narrow therapeutic index medications demand careful attention to dose, laboratory results, interactions, and organ function.
🎯 Exam Strategy: Therapeutic and toxic levels close together = narrow therapeutic index.
Question 19
Morning laboratory results show an abrupt increase in serum creatinine in a patient receiving a medication eliminated predominantly by the kidneys. Which
pharmacokinetic change should the nurse anticipate?
A. Reduced drug clearance and possible accumulation
B. Increased gastrointestinal absorption
C. Increased protein binding
D. Shortened drug half-life
Correct Answer: A
Rationale: A sudden decline in renal function can substantially reduce elimination of renally cleared medications. As clearance decreases, the medication may remain
in circulation longer, prolonging its half-life and increasing the risk of accumulation and toxicity. The nurse should review the dose, dosing interval, renal laboratory
trends, and toxicity manifestations.
Why the other options are less appropriate:
B: Renal impairment does not directly increase gastrointestinal absorption.
C: Protein binding is influenced mainly by plasma proteins and drug characteristics.
D: Decreased clearance usually lengthens, rather than shortens, half-life.
💡 Clinical Pearl: A rising creatinine can convert a previously safe maintenance dose into a toxic regimen.
🎯 Exam Strategy: Renal dysfunction + renally eliminated drug = think decreased clearance first.
Question 20
A medication produces 100% of its expected systemic availability when delivered through one route. Which route most reliably produces this effect?
A. Oral
B. Subcutaneous
C. Intravenous
D. Rectal
Correct Answer: C
Rationale: Intravenous administration places the entire dose directly into systemic circulation, giving essentially 100% bioavailability. Other routes require absorption
across tissues and may be affected by blood flow, gastrointestinal conditions, formulation characteristics, or first-pass metabolism.
Why the other options are less appropriate:
A: Oral medications may undergo incomplete absorption and first-pass metabolism.
B: Subcutaneous drugs require tissue absorption.
D: Rectal absorption may be variable.
💡 Clinical Pearl: IV drugs act quickly because the absorption phase is bypassed.
🎯 Exam Strategy: If the question asks for the route with complete systemic availability, choose IV.
Page 10 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Karch’s Focus on Nursing Pharmacology, 9th Edition
Corrected & Chapter-Aligned Independent Practice TestBank
TestBank features: 1,135 final single-best-answer questions; 60 chapter headings; 11 parts; standardized rationales; rendered diagrams/graphs; balanced A–D
answers; and a complete master answer key.
Important: This is an independent study resource and is not an official publisher test bank. The chapter organization follows the 9th-edition structure. Guideline-
sensitive medication decisions should always be checked against current official product labeling and institutional policy.
Premium Feature Included
Traditional single-best-answer MCQs Four options A–D with one correct answer
Detailed rationales Correct-answer reasoning plus why alternatives are less
appropriate
Clinical pearls High-yield medication-safety and pharmacology connections
Exam strategies Decision cues for nursing pharmacology questions
Calculations/data interpretation Dose, infusion, trends, tables and graph interpretation
Word-visible visuals Rendered flow diagrams, real charts, stable tables and
sketches
Navigation Part/chapter headings, clickable contents and page numbers
Answer integrity One final answer per question; no drafting notes or forced-
answer commentary
Page 2 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Table of Contents
Part / Chapter Title Questions Count Page
PART 1 Introduction to Nursing 150
Pharmacology
Chapter 1 Introduction to Drugs 1–4 4 —
Chapter 2 Drugs and the Body 5–53 49 —
Chapter 3 Toxic Effects of Drugs 54–87 34 —
Chapter 4 The Nursing Process in 88–107 20 —
Drug Therapy and Patient
Safety
Chapter 5 Dosage Calculations 108–138 31 —
Chapter 6 Challenges to Effective 139–150 12 —
Drug Therapy
PART 2 Chemotherapeutic Agents 150
Chapter 7 Introduction to Cell 151–162 12 —
Physiology
Chapter 8 Antiinfective Agents 163–178 16 —
Chapter 9 Antibiotics 179–207 29 —
Chapter 10 Antiviral Agents 208–227 20 —
Chapter 11 Antifungal Agents 228–244 17 —
Chapter 12 Antiprotozoal Agents 245–260 16 —
Chapter 13 Anthelmintic Agents 261–273 13 —
Chapter 14 Antineoplastic Agents 274–300 27 —
PART 3 Drugs Acting on the Immune 150
System
Chapter 15 Introduction to the Immune 301–339 39 —
Response and
Inflammation
Chapter 16 Antiinflammatory, 340–378 39 —
Antiarthritis, and Related
Agents
Chapter 17 Immune Modulators 379–420 42 —
Chapter 18 Vaccines and Sera 421–450 30 —
PART 4 Drugs Acting on the Central 150
and Peripheral Nervous
Systems
Chapter 19 Introduction to Nerves and 451–462 12 —
the Nervous System
Chapter 20 Anxiolytic and Hypnotic 463–480 18 —
Agents
Chapter 21 Antidepressant Agents 481–493 13 —
Chapter 22 Psychotherapeutic Agents 494–512 19 —
Chapter 23 Antiseizure Agents 513–531 19 —
Chapter 24 Antiparkinsonism Agents 532–550 19 —
Chapter 25 Muscle Relaxants 551–555 5 —
Chapter 26 Opioid Agonists, Opioid 556–575 20 —
Antagonists, and
Antimigraine Agents
Chapter 27 General and Local 576–585 10 —
Anesthetic Agents
Chapter 28 Neuromuscular Junction 586–600 15 —
Blocking Agents
PART 5 Drugs Acting on the 80
Autonomic Nervous System
Chapter 29 Introduction to the 601–610 10 —
Autonomic Nervous System
Chapter 30 Adrenergic Agonists 611–625 15 —
Chapter 31 Adrenergic Antagonists 626–640 15 —
Chapter 32 Cholinergic Agonists 641–655 15 —
Chapter 33 Anticholinergic Agents 656–680 25 —
PART 6 Drugs Acting on the Endocrine 75
System
Chapter 34 Introduction to the 681–690 10 —
Endocrine System
Page 3 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 35 Hypothalamic and Pituitary 691–705 15 —
Agents
Chapter 36 Adrenocortical Agents 706–720 15 —
Chapter 37 Thyroid and Parathyroid 721–735 15 —
Agents
Chapter 38 Agents to Control Blood 736–755 20 —
Glucose Levels
PART 7 Drugs Acting on the 75
Reproductive System
Chapter 39 Introduction to the 756–765 10 —
Reproductive System
Chapter 40 Drugs Affecting the Female 766–795 30 —
Reproductive System
Chapter 41 Drugs Affecting the Male 796–830 35 —
Reproductive System
PART 8 Drugs Acting on the 80
Cardiovascular System
Chapter 42 Introduction to the 831–840 10 —
Cardiovascular System
Chapter 43 Drugs Affecting Blood 841–850 10 —
Pressure
Chapter 44 Agents for Treating Heart 851–860 10 —
Failure
Chapter 45 Antiarrhythmic Agents 861–870 10 —
Chapter 46 Antianginal Agents 871–880 10 —
Chapter 47 Lipid-Lowering Agents 881–890 10 —
Chapter 48 Drugs Affecting Blood 891–900 10 —
Coagulation
Chapter 49 Drugs Used to Treat 901–910 10 —
Anemias
PART 9 Drugs Acting on the Renal 75
System
Chapter 50 Introduction to the Renal 911–925 15 —
System
Chapter 51 Diuretic Agents 926–960 35 —
Chapter 52 Drugs Affecting the Urinary 961–985 25 —
Tract and the Bladder
PART 10 Drugs Acting on the 75
Respiratory System
Chapter 53 Introduction to the 986–990 5 —
Respiratory System
Chapter 54 Drugs Acting on the Upper 991–1025 35 —
Respiratory Tract
Chapter 55 Drugs Acting on the Lower 1026–1060 35 —
Respiratory Tract
PART 11 Drugs Acting on the 75
Gastrointestinal System
Chapter 56 Introduction to the 1061–1075 15 —
Gastrointestinal System
Chapter 57 Drugs Affecting 1076–1095 20 —
Gastrointestinal Secretions
Chapter 58 Drugs Affecting 1096–1115 20 —
Gastrointestinal Motility
Chapter 59 Antiemetic Agents 1116–1125 10 —
Chapter 60 Vitamins, Minerals, and 1126–1135 10 —
Complementary/Alternative
Medications
Page 4 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
PART 1 — Introduction to Nursing Pharmacology
Page 5 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 1 — Introduction to Drugs
Question 1
A medication reference lists three names for the same drug: a chemical name, a generic name, and a trade name. Which statement by a nursing student indicates
correct understanding?
A. “The generic name identifies the drug independent of a manufacturer's brand.”
B. “The trade name always describes the medication's chemical structure.”
C. “The chemical name is normally used when administering medications clinically.”
D. “A generic medication must contain a different active ingredient from the brand product.”
Correct Answer: A
Rationale: The generic name is the accepted nonproprietary name of the medication and is not owned as a manufacturer's trademark. Brand or trade names are
assigned by manufacturers. Chemical names describe molecular composition and are typically too complex for routine clinical use.
Why the other options are less appropriate:
B: Trade names are commercial names rather than chemical descriptions.
C: Chemical names are rarely used in routine medication administration.
D: Generic and brand formulations contain the same active medication when equivalent products are compared.
💡 Clinical Pearl: Nurses should become especially comfortable with generic drug names because multiple brands may exist.
🎯 Exam Strategy: Generic = standard name; trade = manufacturer's marketed name.
Question 2
A faculty member asks students to identify the field concerned with selecting and using medications to prevent and treat disease. Which response is correct?
A. Pharmacotherapeutics
B. Pharmacokinetics
C. Toxicology
D. Pharmacognosy
Correct Answer: A
Rationale: Pharmacotherapeutics focuses on the clinical application of medications in preventing, diagnosing, and treating disease. It connects knowledge of drug
action with the therapeutic needs of an individual patient. Nurses use pharmacotherapeutic principles when evaluating whether medication therapy is achieving its
intended clinical outcome.
Why the other options are less appropriate:
B: Pharmacokinetics concerns movement of drugs through the body.
C: Toxicology focuses on harmful effects of chemicals and drugs.
D: Pharmacognosy traditionally concerns drugs derived from natural sources.
💡 Clinical Pearl: Therapeutics = treatment.
🎯 Exam Strategy: Words such as treat, prevent, and clinical use usually point toward pharmacotherapeutics.
Question 3
A medication order requires a trough serum concentration. When should the specimen generally be obtained?
A. Immediately before the next scheduled dose
B. At the expected peak effect
C. Immediately after administration
D. Halfway through the infusion regardless of medication
Correct Answer: A
Rationale: A trough concentration reflects the lowest serum level during a dosing interval and is generally collected immediately before the next dose. Correct timing is
essential because an incorrectly timed sample may lead to inappropriate dose adjustment.
Why the other options are less appropriate:
B: Peak testing measures a different point in the concentration curve.
C: Immediately after administration may reflect a high level.
D: Mid-infusion measurement is not the standard definition of trough.
💡 Clinical Pearl: Always document the exact dose time and specimen time when therapeutic drug monitoring is performed.
🎯 Exam Strategy: Trough = just before.
Question 4
Drug X alone decreases a physiologic response by 20%. Drug Y alone decreases it by 20%, but when administered together the response decreases by 70%. Which
relationship is illustrated?
A. Competitive antagonism
B. Simple tolerance
C. Therapeutic equivalence
D. Synergism
Correct Answer: D
Rationale: Synergism occurs when the combined effect of two drugs exceeds what would be expected from simple addition of their individual effects. This interaction
can be therapeutically useful or potentially dangerous.
Why the other options are less appropriate:
A: Antagonism reduces another drug's effect.
B: Tolerance reflects diminished response with repeated exposure.
C: Therapeutic equivalence does not describe enhanced combined action.
💡 Clinical Pearl: Additive = 1 + 1 ≈ 2; synergistic = 1 + 1 > 2.
🎯 Exam Strategy: Combined effect dramatically exceeds expected sum = synergy.
Page 6 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Chapter 2 — Drugs and the Body
Question 5
During an interdisciplinary conference, a student describes a medication as producing its clinical benefit by attaching to specific cellular receptors and altering cellular
activity. Which pharmacologic concept is the student describing?
A. Pharmacokinetics
B. Pharmacodynamics
C. Pharmacogenomics
D. Pharmacotherapeutics
Correct Answer: B
Rationale: Pharmacodynamics describes what a drug does to the body, including receptor binding, biochemical effects, and the relationship between drug
concentration and therapeutic or toxic responses. Receptor activation or inhibition is therefore primarily a pharmacodynamic process. Understanding this distinction
helps nurses anticipate intended actions as well as receptor-mediated adverse effects.
Why the other options are less appropriate:
A: Pharmacokinetics describes what the body does to the drug through absorption, distribution, metabolism, and excretion.
C: Pharmacogenomics examines genetic influences on medication response.
D: Pharmacotherapeutics concerns the clinical use of drugs to prevent or treat disease.
💡 Clinical Pearl: Think dynamics = drug effect and kinetics = drug movement.
🎯 Exam Strategy: When a question discusses receptors, agonists, antagonists, or cellular effects, think pharmacodynamics.
Question 6
A serum medication level remains unexpectedly elevated in an adult whose renal laboratory values have deteriorated during hospitalization. Which pharmacokinetic
process is most directly impaired?
A. Distribution
B. Absorption
C. Metabolism
D. Excretion
Correct Answer: D
Rationale: The kidneys are major organs responsible for eliminating many medications and their metabolites. Reduced renal function can decrease drug clearance,
prolong the half-life, and cause accumulation. The nurse should recognize elevated medication concentrations as a potential sign that excretion has become
inadequate.
Why the other options are less appropriate:
A: Distribution refers to movement from circulation into tissues.
B: Absorption concerns movement from the administration site into circulation.
C: Metabolism is primarily associated with hepatic biotransformation.
💡 Clinical Pearl: Declining renal function often means lower doses or longer dosing intervals may be required.
🎯 Exam Strategy: Rising creatinine + accumulating drug level = think reduced renal clearance first.
Question 7
Two equal doses of a drug are prescribed. One is administered intravenously and the other orally. Which statement most accurately compares the routes?
A. Oral administration always produces a higher peak concentration.
B. IV medication must first pass through the gastrointestinal tract.
C. IV administration provides essentially immediate systemic availability.
D. Oral and IV medications have identical absorption characteristics.
Correct Answer: C
Rationale: Intravenous administration delivers medication directly into the bloodstream and therefore bypasses the absorption step required by extravascular routes.
IV drugs generally produce rapid onset and complete systemic availability. Oral medications must dissolve, cross gastrointestinal membranes, and may undergo first-
pass hepatic metabolism.
Why the other options are less appropriate:
A: Oral drugs generally do not achieve faster or more reliable peaks than IV administration.
B: IV drugs bypass the gastrointestinal tract.
D: Their pharmacokinetic profiles differ substantially.
💡 Clinical Pearl: IV medication has no absorption barrier, which contributes to both rapid benefits and rapid toxicity.
🎯 Exam Strategy: When comparing administration routes, remember IV = fastest and most directly bioavailable.
Question 8
A medication reconciliation reveals that the hospital admission list omits a patient's long-term anticoagulant. What is the nurse's priority action?
A. Add the medication independently to the electronic MAR.
B. Clarify the discrepancy before continuing the medication plan.
C. Wait until discharge reconciliation to address the omission.
D. Tell the patient to take medication brought from home.
Correct Answer: B
Rationale: Medication reconciliation is designed to identify omissions, duplications, dosing discrepancies, and interactions during transitions in care. An omitted
anticoagulant may place the patient at significant risk, but restarting it also requires confirmation of current indications and contraindications. The discrepancy
therefore requires prompt clarification.
Why the other options are less appropriate:
A: Nurses generally cannot independently prescribe missing medications.
C: Waiting may expose the patient to preventable harm.
D: Unverified self-administration creates additional medication-safety risks.
💡 Clinical Pearl: Transitions of care are particularly vulnerable periods for medication errors.
🎯 Exam Strategy: Reconciliation question + discrepancy = stop and clarify.
Page 7 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Pharmacokinetic Journey
Question 9
A medication taken orally requires a considerably larger dose than the same drug administered intravenously because much of the oral dose is metabolized before
reaching systemic circulation. Which process explains this difference?
A. First-pass effect
B. Receptor down-regulation
C. Renal filtration
D. Drug tolerance
Correct Answer: A
Rationale: After gastrointestinal absorption, many oral medications enter the portal circulation and travel to the liver before reaching systemic circulation. Hepatic
metabolism may inactivate part of the drug during this first passage. Consequently, the amount reaching systemic circulation may be lower than with IV administration.
Why the other options are less appropriate:
B: Receptor down-regulation concerns cellular responsiveness.
C: Renal filtration occurs after systemic circulation and primarily affects elimination.
D: Tolerance develops from repeated exposure and decreased responsiveness.
💡 Clinical Pearl: The first-pass effect can substantially reduce oral bioavailability.
🎯 Exam Strategy: Oral drug + liver metabolism before systemic circulation = first-pass effect.
Question 10
A pharmacology seminar examines a medication whose plasma concentration decreases from 80 mg/L to 40 mg/L in 6 hours. Which conclusion is most accurate?
A. The medication has reached steady state.
B. The therapeutic index is 6 hours.
C. The medication's half-life is approximately 6 hours.
D. Complete elimination occurs after 6 hours.
Correct Answer: C
Rationale: The half-life of a medication is the amount of time required for its plasma concentration to decrease by approximately 50%. A reduction from 80 mg/L to 40
mg/L therefore represents one half-life. Half-life helps determine dosing intervals, accumulation, and the approximate time required for a drug to reach steady state or
be eliminated.
Why the other options are less appropriate:
A: Steady state occurs when drug administration and elimination become approximately balanced.
B: Therapeutic index compares effective and toxic concentrations or doses.
D: One half-life removes only about 50%, not the entire medication.
💡 Clinical Pearl: After roughly 4–5 half-lives, most drugs approach steady state during repeated dosing.
🎯 Exam Strategy: When the concentration falls by exactly half, immediately think half-life.
Question 11
During a receptor-response simulation, Drug X binds to a receptor and produces the same type of cellular response as the body's naturally occurring ligand. How
should Drug X be classified?
A. Agonist
B. Antagonist
C. Enzyme inhibitor
D. Chelating agent
Correct Answer: A
Rationale: An agonist binds to a receptor and activates it, producing a biologic response. Some agonists imitate endogenous chemicals, while others stimulate the
receptor through a different molecular structure. Understanding agonist activity helps predict both desired therapeutic effects and receptor-mediated adverse
reactions.
Why the other options are less appropriate:
B: An antagonist binds without activating the receptor and limits agonist activity.
C: Enzyme inhibition affects metabolism rather than necessarily activating receptors.
D: Chelating agents bind specific substances such as certain metals.
💡 Clinical Pearl: Agonist = activates. Antagonist = blocks.
🎯 Exam Strategy: Look for wording such as stimulates, activates, mimics, or produces a response.
Question 12
Review of a newly prescribed medication shows that it occupies a receptor without activating it and prevents another substance from producing its usual response.
Which mechanism is occurring?
A. Synergism
B. Potentiation
C. Enzyme induction
D. Receptor antagonism
Correct Answer: D
Rationale: A receptor antagonist occupies the receptor but does not activate it. Its presence prevents or reduces the ability of an agonist or naturally occurring ligand to
produce its expected effect. Antagonists are frequently used therapeutically to reverse or limit excessive physiologic stimulation.
Why the other options are less appropriate:
A: Synergism occurs when combined substances produce an enhanced overall effect.
B: Potentiation occurs when one drug increases the effect of another.
C: Enzyme induction increases activity of metabolizing enzymes.
💡 Clinical Pearl: Many emergency reversal medications work through competitive receptor antagonism.
🎯 Exam Strategy: “Occupies but does not activate” is a classic clue for an antagonist.
Page 8 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Question 13
A medication-reconciliation note shows that the individual who cannot swallow is prescribed a medication by the sublingual route. What pharmacokinetic advantage
may this route provide for certain drugs?
A. Complete prevention of drug distribution
B. Rapid absorption with avoidance of much of the first-pass hepatic effect
C. Guaranteed prolonged duration of action
D. Elimination of all adverse effects
Correct Answer: B
Rationale: Sublingual medications can be absorbed through the highly vascular mucosa beneath the tongue and enter systemic circulation rapidly. This route can avoid
substantial first-pass hepatic metabolism because the medication does not first travel through the gastrointestinal tract and portal circulation. The exact advantage
depends on the drug's properties.
Why the other options are less appropriate:
A: Distribution still occurs after systemic absorption.
C: Sublingual administration does not guarantee prolonged action.
D: Adverse effects can still occur.
💡 Clinical Pearl: Sublingual drugs should generally be allowed to dissolve rather than swallowed immediately.
🎯 Exam Strategy: Route question + bypassing liver initially = think sublingual or certain other nonenteral routes.
Question 14
Neurologic rounds focus on why some medications enter brain tissue readily while others do not. Which physiologic structure most directly limits entry of many
substances into the central nervous system?
A. Hepatic portal system
B. Glomerular membrane
C. Blood-brain barrier
D. Gastric mucosa
Correct Answer: C
Rationale: The blood-brain barrier contains tightly connected capillary endothelial cells that restrict passage of many substances from blood into brain tissue. Lipid
solubility, molecular characteristics, transporter activity, and disease states influence whether a drug can cross it. This barrier is an important component of drug
distribution.
Why the other options are less appropriate:
A: The portal system primarily carries gastrointestinal blood to the liver.
B: The glomerulus participates in renal filtration.
D: Gastric mucosa affects absorption of certain substances.
💡 Clinical Pearl: Lipid-soluble medications generally cross cellular membranes more readily than highly ionized compounds.
🎯 Exam Strategy: Questions involving drug penetration into the brain should immediately raise the blood-brain barrier.
Question 15
A medication added to a patient's regimen stimulates hepatic enzymes that metabolize another long-term drug. What may happen to the second drug?
A. Its concentration and therapeutic effect may decrease.
B. Its absorption will necessarily become complete.
C. Its renal filtration will stop.
D. Its receptor affinity will always increase.
Correct Answer: A
Rationale: Enzyme induction increases metabolic enzyme activity and may accelerate metabolism of medications that are substrates for those enzymes. Faster
metabolism can lower serum concentrations and reduce therapeutic effectiveness. The clinical significance depends on the drugs involved and the magnitude of
enzyme induction.
Why the other options are less appropriate:
B: Enzyme induction does not guarantee complete gastrointestinal absorption.
C: It does not stop glomerular filtration.
D: Metabolism and receptor affinity are separate properties.
💡 Clinical Pearl: Enzyme induction often lowers concentrations; enzyme inhibition often raises them.
🎯 Exam Strategy: Memorize the directional relationship rather than isolated definitions.
Question 16
A trend report shows progressively declining renal function in a patient receiving a medication primarily eliminated unchanged in urine. Which adjustment might
eventually be required?
A. Automatic conversion to an intramuscular route
B. Reduction of dose or extension of the dosing interval
C. Addition of another nephrotoxic medication
D. Doubling the dose to improve effectiveness
Correct Answer: B
Rationale: When renal clearance decreases, medications eliminated primarily through the kidneys may remain in the circulation longer. Dose reduction, longer dosing
intervals, or both may be necessary to prevent accumulation. Exact modifications require drug-specific guidance and assessment of renal function.
Why the other options are less appropriate:
A: Changing the route does not necessarily solve impaired elimination.
C: Additional nephrotoxicity could worsen renal dysfunction.
D: Increasing the dose may markedly increase toxicity.
💡 Clinical Pearl: Always connect kidney function to drug clearance, especially for renally eliminated medications.
🎯 Exam Strategy: Renal impairment questions commonly test whether you recognize accumulation risk.
Receptor Activity
Page 9 of 320
, Karch’s Focus on Nursing Pharmacology, 9th Edition | Independent Practice TestBank
Question 17
A medication must achieve an effective plasma concentration rapidly, but its normal maintenance dose would require several dosing intervals to reach that
concentration. Which strategy may be used?
A. Elimination dose
B. Loading dose
C. Placebo dose
D. Rescue interaction
Correct Answer: B
Rationale: A loading dose is a comparatively larger initial dose intended to establish a therapeutic concentration more rapidly. Maintenance doses are then used to
replace drug eliminated from the body and keep the concentration within the desired range. Loading doses require particular caution when the therapeutic index is
narrow.
Why the other options are less appropriate:
A: “Elimination dose” is not the relevant pharmacologic strategy.
C: A placebo does not establish therapeutic drug concentrations.
D: This is not a standard dosing concept.
💡 Clinical Pearl: Loading gets you there; maintenance keeps you there.
🎯 Exam Strategy: Rapid attainment of therapeutic concentration = loading dose.
Question 18
Clinical monitoring is especially intensive for a medication whose effective concentration lies close to its toxic concentration. Which property explains the concern?
A. High bioavailability
B. Extensive first-pass metabolism
C. Long absorption time
D. Narrow therapeutic index
Correct Answer: D
Rationale: A narrow therapeutic index means there is a relatively small margin between therapeutic and toxic drug exposure. Small changes in dosage, metabolism,
renal function, or interacting medications may therefore result in toxicity or treatment failure. Serum drug levels may be required for certain medications in this
category.
Why the other options are less appropriate:
A: High bioavailability alone does not establish a narrow safety margin.
B: First-pass metabolism concerns oral bioavailability.
C: Absorption time does not define the toxic-to-therapeutic relationship.
💡 Clinical Pearl: Narrow therapeutic index medications demand careful attention to dose, laboratory results, interactions, and organ function.
🎯 Exam Strategy: Therapeutic and toxic levels close together = narrow therapeutic index.
Question 19
Morning laboratory results show an abrupt increase in serum creatinine in a patient receiving a medication eliminated predominantly by the kidneys. Which
pharmacokinetic change should the nurse anticipate?
A. Reduced drug clearance and possible accumulation
B. Increased gastrointestinal absorption
C. Increased protein binding
D. Shortened drug half-life
Correct Answer: A
Rationale: A sudden decline in renal function can substantially reduce elimination of renally cleared medications. As clearance decreases, the medication may remain
in circulation longer, prolonging its half-life and increasing the risk of accumulation and toxicity. The nurse should review the dose, dosing interval, renal laboratory
trends, and toxicity manifestations.
Why the other options are less appropriate:
B: Renal impairment does not directly increase gastrointestinal absorption.
C: Protein binding is influenced mainly by plasma proteins and drug characteristics.
D: Decreased clearance usually lengthens, rather than shortens, half-life.
💡 Clinical Pearl: A rising creatinine can convert a previously safe maintenance dose into a toxic regimen.
🎯 Exam Strategy: Renal dysfunction + renally eliminated drug = think decreased clearance first.
Question 20
A medication produces 100% of its expected systemic availability when delivered through one route. Which route most reliably produces this effect?
A. Oral
B. Subcutaneous
C. Intravenous
D. Rectal
Correct Answer: C
Rationale: Intravenous administration places the entire dose directly into systemic circulation, giving essentially 100% bioavailability. Other routes require absorption
across tissues and may be affected by blood flow, gastrointestinal conditions, formulation characteristics, or first-pass metabolism.
Why the other options are less appropriate:
A: Oral medications may undergo incomplete absorption and first-pass metabolism.
B: Subcutaneous drugs require tissue absorption.
D: Rectal absorption may be variable.
💡 Clinical Pearl: IV drugs act quickly because the absorption phase is bypassed.
🎯 Exam Strategy: If the question asks for the route with complete systemic availability, choose IV.
Page 10 of 320
